Current Report Filing (8-k)
17 Mayo 2023 - 7:06AM
Edgar (US Regulatory)
0001651561
false
0001651561
2023-05-17
2023-05-17
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
May 17, 2023
Tabula Rasa HealthCare, Inc.
(Exact Name of Registrant as Specified in its
Charter)
Delaware |
|
001-37888 |
|
46-5726437 |
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
228 Strawbridge Drive, Suite 100
Moorestown, New Jersey 08057
(Address of Principal Executive Offices, and
Zip Code)
(866) 648-2767
Registrant’s Telephone Number, Including
Area Code
Not Applicable
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
|
¨ |
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which
registered |
Common Stock, par value $0.0001 |
TRHC |
The Nasdaq Stock Market |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ¨
| Item 7.01. | Regulation FD Disclosure. |
On May 17, 2023, Tabula Rasa HealthCare, Inc.
(the “Company”) posted an investor presentation on the “Investors” section of its website at ir.tabularasahealthcare.com.
A copy of the investor presentation is attached hereto as Exhibit 99.1, and is incorporated by reference herein.
The information furnished pursuant to this Item
7.01 and the accompanying Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated
by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference
in such filing.
Website addresses are included as inactive textual
references only. The information contained on the website referenced herein is not incorporated into this Current Report on Form 8-K.
Important information may be disseminated initially or exclusively via the Company’s corporate website; investors should consult
the site to access this information.
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
TABULA
RASA HEALTHCARE, INC. |
|
|
|
By: |
/s/ Brian W. Adams |
|
|
Brian W. Adams |
|
|
President and Chief Executive Officer |
Dated: May 17, 2023
Tabula Rasa HealthCare (NASDAQ:TRHC)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Tabula Rasa HealthCare (NASDAQ:TRHC)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024